Brown D - Search Results

1

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region.

Castellsagué X, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris DG, Joura EA, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Monsonego J, Muñoz N, Myers E, Paavonen J, Pitisuttihum P, Steben M, Wheeler CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C. Castellsagué X, et al. Among authors: brown d. Papillomavirus Res. 2016 Dec;2:61-69. doi: 10.1016/j.pvr.2016.03.002. Epub 2016 Mar 14. Papillomavirus Res. 2016. PMID: 29074187 Free PMC article.

2

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.

Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Miller D, Monsonego J, Munoz N, Myers E, Paavonen J, Pitisuttithum P, Steben M, Wheeler CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C. Joura EA, et al. Among authors: brown d. Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1997-2008. doi: 10.1158/1055-9965.EPI-14-0410. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 25274978 Clinical Trial.

3

Clarification on the impact of cervarix vaccination on human papillomavirus infection and cervical cancer in the United Kingdom.

Brown D, Kulkarni AS, Pillsbury M, Luxembourg A, Saah A. Brown D, et al. Hum Vaccin Immunother. 2016 Jul 2;12(7):1940-2. doi: 10.1080/21645515.2016.1143159. Hum Vaccin Immunother. 2016. PMID: 26857560 Free PMC article. No abstract available.

4

Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine.

Luxembourg A, Brown D, Bouchard C, Giuliano AR, Iversen OE, Joura EA, Penny ME, Restrepo JA, Romaguera J, Maansson R, Moeller E, Ritter M, Chen J. Luxembourg A, et al. Among authors: brown d. Hum Vaccin Immunother. 2015;11(6):1313-22. doi: 10.1080/21645515.2015.1012010. Hum Vaccin Immunother. 2015. PMID: 25912208 Free PMC article. Clinical Trial.

5

Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.

Brown D, Müller M, Sehr P, Pawlita M, Seitz H, Rubio I, Antonello J, Radley D, Roberts C, Saah A. Brown D, et al. Vaccine. 2014 Oct 7;32(44):5880-7. doi: 10.1016/j.vaccine.2014.08.004. Epub 2014 Aug 19. Vaccine. 2014. PMID: 25148777

6

Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women.

Whittemore D, Ding L, Widdice LE, Brown DA, Bernstein DI, Franco EL, Kahn JA. Whittemore D, et al. Among authors: brown da. J Womens Health (Larchmt). 2016 Nov;25(11):1153-1158. doi: 10.1089/jwh.2015.5674. Epub 2016 Oct 18. J Womens Health (Larchmt). 2016. PMID: 27754751 Free PMC article.

7

Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction.

Covert C, Ding L, Brown D, Franco EL, Bernstein DI, Kahn JA. Covert C, et al. Among authors: brown d. Hum Vaccin Immunother. 2019;15(7-8):1962-1969. doi: 10.1080/21645515.2018.1564438. Epub 2019 Feb 20. Hum Vaccin Immunother. 2019. PMID: 30633598 Free PMC article.

8

Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.

Chandler E, Ding L, Gorbach P, Franco EL, Brown DA, Widdice LE, Bernstein DI, Kahn JA. Chandler E, et al. J Adolesc Health. 2018 Jul;63(1):43-49. doi: 10.1016/j.jadohealth.2018.01.005. J Adolesc Health. 2018. PMID: 30060856 Free PMC article.

9

Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection.

Saccucci M, Franco EL, Ding L, Bernstein DI, Brown D, Kahn JA. Saccucci M, et al. Among authors: brown d. Sex Transm Dis. 2018 Apr;45(4):260-265. doi: 10.1097/OLQ.0000000000000731. Sex Transm Dis. 2018. PMID: 29465705 Free PMC article.

10

Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy.

Aikio M, Odeh HM, Wobst HJ, Lee BL, Chan Ú, Mauna JC, Mack KL, Class B, Ollerhead TA, Ford AF, Barbieri EM, Cupo RR, Drake LE, Smalley JL, Lin YT, Lam S, Thomas R, Castello N, Baral A, Beyer JN, Najar MA, Dunlop J, Gitler AD, Javaherian A, Kaye JA, Burslem GM, Brown DG, Donnelly CJ, Finkbeiner S, Moss SJ, Brandon NJ, Shorter J. Aikio M, et al. Among authors: brown dg. Cell Rep. 2025 Jan 14;44(1):115205. doi: 10.1016/j.celrep.2024.115205. Online ahead of print. Cell Rep. 2025. PMID: 39817908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,218 results

Search Page

Filters